This website is currently undergoing maintenance.

Thank you for your patience. Please check back later. Adverse events should be reported to your regulatory agency. Adverse events should also be reported to your local distributor or Norgine Limited, Norgine House, Moorhall Road, Harefield, Uxbridge, Middlesex, UB9 6NS, United Kingdom. Email: GPharmacoVigilance@norgine.com

For any other enquiries, please contact Norgine at contact@norgine.com.

August 2023
GL-HEP-XIF-2300005